The Receptor for Type I IFNs Is Highly Expressed on Peripheral Blood B Cells and Monocytes and Mediates a Distinct Profile of Differentiation and Activation of These Cells

Journal of Interferon and Cytokine Research

Volumn 24, Issue 2, 2004, Pages 131-139

  Pogue, Sarah L ^a,b   Preston, Benjamin T ^a,b   Stalder, Joseph ^a   Bebbington, Christopher R ^a,c   Cardarelli, Pina M ^a,b  

^a GLAXOSMITHKLINE   (United States)

^b Medarex Inc   (United States)

^c KaloBios Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR ANTIBODY; ALPHA2B INTERFERON; BETA INTERFERON; CD123 ANTIGEN; CD14 ANTIGEN; CD32 ANTIGEN; CD38 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON RECEPTOR; INTERLEUKIN 4; LYMPHOCYTE SURFACE MARKER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECEPTOR ANTIBODY; RECOMBINANT ALPHA2B INTERFERON; T6 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; DENDRITIC CELL; DRUG POTENCY; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MONOCYTE; MONONUCLEAR CELL; MORPHOLOGY; PRIORITY JOURNAL;

EID: 1342288115     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999004322813372     Document Type: Article

References (30)

1. DIAZ, M.O., POMYKALA, H.M., BOHLANDER, S.K., MALTEPE, E., MALIK, K., BROWNSTEIN, B., and OLOPADE, O.I. (1994). Structure of the human type I interferon gene cluster determined from a YAC clone contig. Genomics 22, 540-552.
2. PESTKA, S., LANGER, J.A., ZOON, K.C., and SAMUEL, C.E. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
3. MOGENSEN, K.E., LEWERENZ, M., REBOUL, J., LUTFALLA, G., and UZE, G. (1999). The type I interferon receptor: structure, function, and evolution of a family business. J. Interferon Cytokine Res. 19, 1069-1098.
4. COOK, J.R., CLEARY, C.M., MARIANO, T.M., IZOTOVA, L., and PESTKA, S. (1996). Differential responsiveness of a splice variant of the human type I interferon receptor to interferons. J. Biol. Chem. 271, 13448-13453.
5. LEWERENZ, M., MOGENSEN, K.E., and UZE, G. (1998). Shared receptor components but distinct complexes for alpha and beta interferons. J. Mol. Biol. 282, 585-599.
6. HALLER, O., ARNHEITER, H., GRESSER, I., and LINDENMANN, J. (1981). Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J. Exp. Med. 154, 199-203.
7. LINDENMANN, J. (1981). Induction of chick interferon: procedures of the original experiments. Methods Enzymol. 78, 181-188.
8. + T cells. J. Exp. Med. 178, 1655-1663.
9. FINKELMAN, F.D., SVETIC, A., GRESSER, I., SNAPPER, C., HOLMES, J., TROTTA, P.P., KATONA, I.M., and GAUSE, W.C. (1991). Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J. Exp. Med. 174, 1179-1188.
10. TOUGH, D.F., BORROW, P., and SPRENT, J. (1996). Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950.
11. LUFT, T., PANG, K.C., THOMAS, E., HERTZOG, P., HART, D.N., TRAPANI, J., and CEBON, J. (1998). Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161, 1947-1953.
12. LUFT, T., LUETJENS, P., HOCHREIN, H., TOY, T., MASTERMAN, K.A., RIZKALLA, M., MALISZEWSKI, C., SHORTMAN, K., CEBON, J., and MARASKOVSKY, E. (2002). IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int. Immunol. 14, 367-380.
13. PAQUETTE, R.L., HSU, N.C., KIERTSCHER, S.M., PARK, A.N., TRAN, L., ROTH, M.D., and GLASPY, J.A. (1998). Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leukocyte Biol. 64, 358-367.
14. SANTINI, S.M., LAPENTA, C., LOGOZZI, M., PARLATO, S., SPADA, M., DI PUCCHIO, T., and BELARDELLI, F. (2000). Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191, 1777-1788.
15. RADVANYI, L.G., BANERJEE, A., WEIR, M., and MESSNER, H. (1999). Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerate dendritic cell maturation from human peripheral blood mononuclear cells. Scand. J. Immunol. 50, 499-509.
16. BENOIT, P., MAGUIRE, D., PLAVEC, I., KOCHER, H., TOVEY, M., and MEYER, F. (1993). A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor. J. Immunol. 150, 707-716.
17. MUSSO, T., DEAGLIO, S., FRANCO, L., CALOSSO, L., BADOLATO, R., GARBARINO, G., DIANZANI, U., and MALAVASI, F. (2001). CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines. J. Leukocyte Biol. 69, 605-612.
18. MONDINO, A., and JENKINS, M.K. (1994). Surface proteins involved in T cell costimulation. J. Leukocyte Biol. 55, 805-815.
19. PIEHLER, J., and SCHREIBER, G. (1999). Mutational and structural analysis of the binding interface between type I interferons and their receptor IFNAR-2. J. Mol. Biol. 294, 223-237.
20. RUSSELL-HARDE, D., WAGNER, T.C., PEREZ, H.D., and CROZE, E. (1999). Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation. Biochem. Biophys. Res. Commun. 255, 539-544.
21. SALLUSTO, F., and LANZAVECCHIA, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
22. ROMANI, N., GRUNER, S., BRANG, D., KAMPGEN, E., LENZ, A., TROCKENBACHER, B., KONWALINKA, G., FRITSCH, P.O., STEINMAN, R.M., and SCHULER, G. (1994). Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93.
23. BLANCO, P., PALUCKA, A.K., GILL, M., PASCUAL, V., and BANCHEREAU, J. (2001). Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294, 1540-1543.
24. GAUZZI, M.C., CANINI, I., EID, P., BELARDELLI, F., and GESSANI, S. (2002). Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells. J. Immunol. 169, 3038-3045.
25. GALIBERT, L., BURDIN, N., DE SAINT-VIS, B., GARRONE, P., VAN KOOTEN, C., BANCHEREAU, J., and ROUSSET, F. (1996). CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med. 183, 77-85.
26. HUANG, Y.M., XIAO, B.G., OZENCI, V., KOUWENHOVEN, M., TELESHOVA, N., FREDRIKSON, S., and LINK, H. (1999). Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J. Neuroimmunol. 99, 82-90.
27. VAN DEN BROEK, M.F., MULLER, U., HUANG, S., ZINKER-NAGEL, R.M., and AGUET, M. (1995). Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148, 5-18.
28. YTTERBERG, S.R., and SCHNITZER, T.J. (1982). Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25, 401-406.
29. HOOKS, J.J., JORDAN, G.W., CUPPS, T., MOUTSOPOULOS, H.M., FAUCI, A.S., and NOTKINS, A.L. (1982). Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum. 25, 396-400.
30. BATTEUX, F., PALMER, P., DAERON, M., WEILL, B., and LEBON, P. (1999). FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus. Eur. Cytokine Netw. 10, 509-514.